RDCC Staff

Executive Director

Stacey Frisk

Director, Public Affairs & Operations

Yoko Rosenbaum

Manager, Government Affairs

Zach Schulz

Executive Committee

Chair

Del Lebel
Alexion, AstraZeneca Rare Disease

Vice Chair

Curt Oltmans
Fulcrum Therapeutic

Secretary

Michael Calvo
BridgeBio

Treasurer

Christopher Porter
Travere Therapeutics

Member-at-Large, Clinical / Pre-Clinical

Matt Winton
Inozyme Pharma

Member-at-Large, Commercial

Diane Berry
Sarepta Therapeutics

Committee Chairs

Federal Policy Committee Co-Chair

Lisa Kahlman
Ultragenyx

Federal Policy Committee Co-Chair

Aaron Krupp
Agios Therapeutics

Federal Policy Committee Co-Chair

Andrea Hofelich
Alexion, AstraZeneca Rare Disease

Federal Policy Committee Co-Chair

Joey Fleury
Ultragenyx